{"title":"Microdosing of LSD does not show efficacy in adults with ADHD","authors":"","doi":"10.1002/pu.31324","DOIUrl":null,"url":null,"abstract":"<p>Microdosing of lysergic acid diethylamide (LSD) over a 6-week period showed no significant benefits over placebo in reducing symptoms of attention-deficit hyperactivity disorder (ADHD) in adults, a Phase 2A trial has found. Both the LSD and placebo groups experienced marked improvement, the investigators reported.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31324","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Microdosing of lysergic acid diethylamide (LSD) over a 6-week period showed no significant benefits over placebo in reducing symptoms of attention-deficit hyperactivity disorder (ADHD) in adults, a Phase 2A trial has found. Both the LSD and placebo groups experienced marked improvement, the investigators reported.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
